A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood
Clinical trial NCT03886272 · COMPLETED
Trial details
- NCT number
- NCT03886272
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2019-06-21
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.